A carregar...
Ibrutinib (PCI-32765) in Chronic Lymphocytic Leukemia
B-cell receptor (BCR) signaling is essential for chronic lymphocytic leukemia (CLL) cell survival. Many kinases in the BCR signaling pathway are currently being studied as potential therapeutic targets. These include Lyn, Syk, PI3 and Bruton tyrosine (BTK). Ibrutinib (PCI-32765) is a novel first-in-...
Na minha lista:
| Publicado no: | Hematol Oncol Clin North Am |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4449150/ https://ncbi.nlm.nih.gov/pubmed/23915749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2013.01.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|